Literature DB >> 6296728

Fatal peripheral neurolymphomatosis after remission of histiocytic lymphoma.

Y Shoenfeld, D Aderka, U Sandbank, N Gadot, M Santo, J Pinkhas.   

Abstract

A 32-year-old woman with histiocytic lymphoma was in complete clinical remission after two courses of chemotherapy, when peripheral neuropathy developed fulminantly. Abnormalities included facial nerve paralysis, dysphagia, quadriparesis, myalgia, and incontinence. She died 10 days after onset of these symptoms. Postmortem examination revealed infiltration of peripheral nerves by lymphomatous cells with no involvement of meninges, brain, lymph nodes, or other organs. Differences in the blood-brain barrier of peripheral and central nervous system are suggested: The peripheral barrier may be more penetrable by malignant histiocytes or less permeable to cytotoxic drugs. Intrathecal chemotherapeutic drug instillation and irradiation may be beneficial.

Entities:  

Mesh:

Year:  1983        PMID: 6296728     DOI: 10.1212/wnl.33.2.243

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Acute demyelinating neuropathy in a patient with neurolymphomatosis.

Authors:  Rola A Mahmoud; Charles K Abrams
Journal:  BMJ Case Rep       Date:  2018-03-05

Review 2.  Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classification.

Authors:  C Vital; A Vital; J Julien; J Rivel; A deMascarel; B Vergier; P Henry; M Barat; J Reiffers; A Broustet
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

3.  B cell small lymphocytic lymphoma and chronic lymphocytic leukemia with peripheral neuropathy: two cases with neuropathological findings and lymphocyte marker analysis.

Authors:  F P Thomas; U Vallejos; D R Foitl; J R Miller; R Barrett; M R Fetell; D M Knowles; N Latov; A P Hays
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.